Meeting NewsVideo

VIDEO: Oral eplerenone successfully treats central serous chorioretinopathy

NEPTUNE, N.J. – A 58-year-old man with distorted vision was diagnosed with central serous chorioretinopathy and was successfully treated with oral eplerenone, 25 mg twice a day, according to Yuyeng Lor, OD, MPH, here at a New Jersey Academy of Optometry continuing education event.

This mineralocorticoid receptor agonist acts as a diuretic, Lor said, and at the patient’s 6-month follow-up the subretinal fluid had resolved, and his vision returned to 20/20.

The NJAO provided a grant for Lor to present her research at the American Academy of Optometry meeting.

Disclosure: Lor reports no relevant financial disclosures.

NEPTUNE, N.J. – A 58-year-old man with distorted vision was diagnosed with central serous chorioretinopathy and was successfully treated with oral eplerenone, 25 mg twice a day, according to Yuyeng Lor, OD, MPH, here at a New Jersey Academy of Optometry continuing education event.

This mineralocorticoid receptor agonist acts as a diuretic, Lor said, and at the patient’s 6-month follow-up the subretinal fluid had resolved, and his vision returned to 20/20.

The NJAO provided a grant for Lor to present her research at the American Academy of Optometry meeting.

Disclosure: Lor reports no relevant financial disclosures.